Immunological Responses in Equine Insect Bite Hypersensitivity

Insect bite hypersensitivity in horses arises when salivary proteins from Culicoides midges breach the skin barrier and initiate a biphasic allergic reaction. The immediate phase is driven by allergen-specific IgE bound to mast cells, leading to degranulation and release of histamine. Within days a delayed phase emerges, characterised by infiltration of eosinophils and Th2-polarised lymphocytes that produce interleukins such as IL-5 and IL-13. Disruption of tight junctions in the epidermis appears to predispose to allergen entry and amplifies local inflammation. Circulating IgE+ plasmablasts and specialised monocytes that bear high-affinity IgE receptors further propagate the response by secreting cytokines and interacting with coagulation factors in lesioned skin. These coordinated innate and adaptive pathways drive pruritus, excoriation and chronic dermatitis. Understanding these mechanisms is vital not only for equine welfare but also as a natural model for human atopic dermatitis. Recent advances have illuminated predictive biomarkers and novel interventions that target key cytokines, offering prospects for prophylactic vaccination and therapeutic antibodies to modulate eosinophil activity.

Research from Nature Portfolio

A novel therapeutic antibody against equine interleukin 5 has been generated through phage-display technology and iterative in vitro affinity maturation. This chimeric immunoglobulin G binds IL-5 with nanomolar affinity and inhibits its interaction with the receptor at low nanomolar concentrations, thereby preventing eosinophil activation. The lead candidate exhibits favourable stability and manufacturability profiles, making it a promising intervention to block the recruitment and survival of eosinophils in insect bite hypersensitivity. In vivo studies are anticipated to validate its efficacy in reducing clinical signs and improving skin lesions.

Research from all publishers

Investigations into equine allergen responses have identified IgE+ plasmablasts in peripheral blood as early predictors of clinical hypersensitivity, appearing up to three weeks before overt signs and correlating closely with disease onset. Parallel transcriptomic analysis of IgE-binding monocytes has revealed upregulation of coagulation cascade components, notably fibrinoligase subunit F13A1, and downregulation of the chemokine receptor CCR10 during the active season, implicating these cells in both inflammatory amplification and impaired skin homoeostasis. Together these studies furnish actionable biomarkers and elucidate cellular drivers that bridge systemic immunity and cutaneous pathology, guiding targeted diagnostics and tailored therapies.

Immunological Responses in Equine Insect Bite Hypersensitivity publication trend

The graph below shows the total number of articles in immunological responses in equine insect bite hypersensitivity across all publications each year (not limited to Nature Index journals).

Technical terms

Culicoides spp.: Genus of biting midges whose salivary allergens trigger equine insect bite hypersensitivity.

Type I/IVb hypersensitivity: Combined immediate (IgE-mediated) and delayed (eosinophil-dominated) allergic reactions.

IgE+ plasmablast: Activated B cell subset secreting immunoglobulin E shortly after allergen exposure.

IgE-binding monocyte: Peripheral blood monocyte expressing high-affinity receptors for IgE and contributing to allergic inflammation.

Interleukin-5 (IL-5): Cytokine essential for eosinophil maturation, activation and survival in allergic responses.

References

1. IgE+ plasmablasts predict the onset of clinical allergy. Frontiers in Immunology (2023).
2. IgE-binding monocytes upregulate the coagulation cascade in allergic horses. Genes & Immunity (2023).
3. Investigating the epithelial barrier and immune signatures in the pathogenesis of equine insect bite hypersensitivity. PLOS ONE (2020).
4. Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horses. Scientific Reports (2023).